{"url":"https://lda.senate.gov/api/v1/filings/a2bc70c8-6425-48ad-bfd8-e6c86e6cecf9/","filing_uuid":"a2bc70c8-6425-48ad-bfd8-e6c86e6cecf9","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2010,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/a2bc70c8-6425-48ad-bfd8-e6c86e6cecf9/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"David Gencarelli, President","dt_posted":"2010-08-08T15:54:12.567000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"209 Pennsylvania Avenue, SE","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20003","registrant":{"id":15918,"url":"https://lda.senate.gov/api/v1/registrants/15918/","house_registrant_id":40079,"name":"DAVID GENCARELLI","description":"Legislative and regulatory consultant","address_1":"1349 East Capitol Street, SE","address_2":"Apt A","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20003","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVID GENCARELLI","contact_telephone":"+1 202-256-6191","dt_updated":"2026-01-31T20:26:41.798643-05:00"},"client":{"id":121508,"url":"https://lda.senate.gov/api/v1/clients/121508/","client_id":327,"name":"NANOVIRICIDES INC","general_description":"Bio-Tech Research company","client_government_entity":false,"client_self_select":false,"state":"CT","state_display":"Connecticut","country":"US","country_display":"United States of America","ppb_state":"CT","ppb_state_display":"Connecticut","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-03-14"},"lobbying_activities":[{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Defense Appropriations Legislation FY 2011\nDefense Threat Reduction Agency--Viral Disease Research","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":48227,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"F","last_name":"GENCARELLI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":44412,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"LEE","last_name":"WERNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":236,"name":"Defense Threat Reduction Agency (DTRA)"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}